Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies

 Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies

Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Shots:

  • The companies enter in a global Ab manufacturing collaboration to expedite the global supply of Lilly’s COVID-19 therapies
  •  With the agreement, the two companies will have the ability to ramp up the production and serve more patients globally, once Lilly’s Ab therapies prove successful in clinical testing and receive regulatory approval
  • Lilly is currently evaluating multiple neutralizing Abs for the prevention and/or treatment of COVID-19 as either monothx. or as combination therapy. Amgen will leverage its technical expertise in antibody development and capabilities in the scale-up and manufacturing of complex biologics

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Genetic Engineering and Biotechnology News

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post